Literature DB >> 7606201

No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.

Y Sun1, A Hildesheim, H Li, Y Li, J Y Chen, Y J Cheng, R B Hayes, N Rothman, W F Bi, Y Cao.   

Abstract

Mutational inactivation of the p53 tumor suppressor gene is an infrequent event in human nasopharyngeal carcinoma (NPC), a malignancy showing a high incidence in southern China and southeast Asia. To examine the possible involvement of an activated p53 pathway in nasopharynx carcinogenesis, we have screened primary NPC biopsies for possible point mutations in WAF-1/CIP-1/p21, an effector gene transcriptionally regulated by and functioning as a mediator of the p53 tumor suppressor gene. Mutations in WAF-1/CIP-1/p21 might mimic p53 mutations in tumors having wild-type p53 such as most NPCs. The mutational analysis of WAF/CIP/p21 by PCR-single strand conformational polymorphism-direct sequencing revealed no point mutation in 41 primary NPC biopsies. A codon 31ser-->arg polymorphism was, however, detected. A striking difference in the distribution of the serine (WAF-ser) and arginine (WAF-arg) forms of WAF-1/CIP-1/p21 was observed when normal healthy Caucasians and Chinese were compared (P < 0.0001). The majority of Caucasians examined were found to be homozygous for WAF-ser (89%, n = 65), while Chinese living in areas of high NPC incidence show a greater than 86% homozygous or heterozygous WAF-arg (Taiwan, n = 66; Hunan, n = 32). The two forms of WAF-1/CIP-1/p21 were examined for potential functional differences in their ability to inhibit cyclin-dependent kinases and tumor cell growth. No significant differences were detected. Furthermore, no association between WAF-1/CIP-1/p21 genotype and NPC risk was observed in a case-control study of 76 NPC cases and 66 normal controls conducted in Taiwan.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606201

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

3.  Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

4.  Absence of p21 WAF1 and p27 kip1 gene mutations in various feline tumours.

Authors:  B Mayr; B Wilhelm; M Reifinger; G Brem
Journal:  Vet Res Commun       Date:  2000-03       Impact factor: 2.459

5.  Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma.

Authors:  Ming-Hsui Tsai; Wen-Chi Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

6.  Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia.

Authors:  Sandra Liliana Vargas-Torres; Elyzabeth Avvad Portari; Amanda Lima Silva; Evandro Mendes Klumb; Heloísa Carneiro da Rocha Guillobel; Maria José de Camargo; Cíntia Barros Santos-Rebouças; Fábio Bastos Russomano; Jacyara Maria Brito Macedo
Journal:  Tumour Biol       Date:  2016-02-05

Review 7.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

8.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

9.  p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.

Authors:  S Mousses; N Gokgoz; J S Wunder; H Ozcelik; S Bull; R S Bell; I L Andrulis
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

10.  Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.

Authors:  Tomoko Yoneda; Ayumi Kuboyama; Kiyoko Kato; Tatsuhiro Ohgami; Kanako Okamoto; Toshiaki Saito; Norio Wake
Journal:  Oncol Rep       Date:  2013-04-29       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.